Market
Lanes are never summed. Equity is Form D filings and matched press rounds; awards and exits will have their own sources.
Health & bio: subsectors
6 subsectors, sized by amount sold · 90 days to 2026-10-04 · as of 2026-10-0416 rounds not yet in a sector
16 rounds not yet in a sector
- ▲ Rising
- Steady
- Leaning (80%)
- ▼ Falling
- Quiet
Coloured by subsector state, 28 days to 2026-10-03 vs prior 28; shaded when the change is clear at 90% confidence, palest when only at 80%.
Equity · amount sold
Capital by week
Dollars sold per filing week, round count under each bar · 4 weeks to 2026-10-04 · as of 2026-10-04Stage mix
Inferred stage · 90 days to 2026-10-04 · as of 2026-10-04- Pre-seed123 roundsPre-seed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $157MAmount sold in original Pre-seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Seed383 roundsSeed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.2BAmount sold in original Seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series A287 roundsSeries A rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.7BAmount sold in original Series A filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series B88 roundsSeries B rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.5BAmount sold in original Series B filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series C+84 roundsSeries C+ rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $28.8BAmount sold in original Series C+ filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Stage not inferred7 roundsStage not inferred rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.0BAmount sold in original Stage not inferred filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
Bar length is each stage’s share of the window’s rounds. Dollars of original filings only: an amendment’s restated amount counts in the map, not here. Stage is inferred from the amount sold, never stated on Form D; a stage named in a press release wins.
Where it landed
Which states the money was raised from, by the company's HQ · 90 days to 2026-10-04 · as of 2026-10-04- $0+
- $353M+
- $1.4B+
- $3.2B+
- $5.7B+
Mega-rounds shown separately (see the band above)
Rounds
Newest first · every row traces to a Form D on EDGAR or a matched press release · as of 2026-10-04| Company | Sector | Stage | Sold of offered | Filed | HQ | Exemption | Open roles | Hiring | Flags | |
|---|---|---|---|---|---|---|---|---|---|---|
| Precision Digital HealthQuiet$5.6M of $6.3M · Seed · Health & bio · 506(b) · Irvine, CA · 2026-07-20 | Precision Digital Health | Health & bio | Seed | $5.6M of $6.3MAmount sold of the amount offered on the filing of 2026-07-20 · as of 2026-10-04How this is computed → | 2026-07-20 | Irvine, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| QuantelixHiring actively$4.3M of $4.3M · Seed · Health & bio · 504 · Pasadena, CA · 2026-07-17 | Quantelix | Health & bio | Seed | $4.3M of $4.3MAmount sold of the amount offered on the filing of 2026-07-17 · as of 2026-10-04How this is computed → | 2026-07-17 | Pasadena, CA | 504 | 3The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Shape Memory MedicalQuiet$6.9M of $10.0M · Series A · Health & bio · 506(b) · San Jose, CA · 2026-07-16Amended | Shape Memory MedicalAmended | Health & bio | Series A | $6.9M of $10.0MAmount sold of the amount offered as of the filing of 2026-07-31 · as of 2026-10-04How this is computed → | 2026-07-16 | San Jose, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | Amended |
| Sinopia BiosciencesHiring actively$2.8M of $4.3M · Seed · Health & bio · 506(b) · San Diego, CA · 2026-07-16 | Sinopia Biosciences | Health & bio | Seed | $2.8M of $4.3MAmount sold of the amount offered on the filing of 2026-07-16 · as of 2026-10-04How this is computed → | 2026-07-16 | San Diego, CA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| ImmunoVecHiring actively$12.7M of $15.0M · Series A · Health & bio · 506(b) · Los Angeles, CA · 2026-07-14 | ImmunoVec | Health & bio | Series A | $12.7M of $15.0MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | Los Angeles, CA | 506(b) | 3The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Laxmi Therapeutic DevicesHiring actively$2.1M of $2.1M · Seed · Health & bio · 506(b) · Goleta, CA · 2026-07-14 | Laxmi Therapeutic Devices | Health & bio | Seed | $2.1M of $2.1MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | Goleta, CA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Reticle Biosystems, Inc.Quiet$1.0M of $1.0M · Pre-seed · Health & bio · 506(b) · San Francisco, CA · 2026-07-14 | Reticle Biosystems, Inc. | Health & bio | Pre-seed | $1.0M of $1.0MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | San Francisco, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Procode AIQuiet$9.5M of $10.0M · Series A · Health & bio · 506(b) · Los Angeles, CA · 2026-07-13AI-native | Procode AIAI-native | Health & bio | Series A | $9.5M of $10.0MAmount sold of the amount offered on the filing of 2026-07-13 · as of 2026-10-04How this is computed → | 2026-07-13 | Los Angeles, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| Vantis VascularQuiet$18.6M of $21.5M · Series A · Health & bio · 506(b) · San Jose, CA · 2026-07-10 | Vantis Vascular | Health & bio | Series A | $18.6M of $21.5MAmount sold of the amount offered on the filing of 2026-07-10 · as of 2026-10-04How this is computed → | 2026-07-10 | San Jose, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| CeleCor TherapeuticsQuiet$11.9M of $15.0M · Series A · Health & bio · 506(b) · Del Mar, CA · 2026-07-09 | CeleCor Therapeutics | Health & bio | Series A | $11.9M of $15.0MAmount sold of the amount offered on the filing of 2026-07-09 · as of 2026-10-04How this is computed → | 2026-07-09 | Del Mar, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AmlogenyxQuiet$10.0M of $20.0M · Series A · Health & bio · 506(b) · Novato, CA · 2026-07-09 | Amlogenyx | Health & bio | Series A | $10.0M of $20.0MAmount sold of the amount offered on the filing of 2026-07-09 · as of 2026-10-04How this is computed → | 2026-07-09 | Novato, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AllswellHiring actively$6.8M of $8.3M · Series A · Health & bio · 506(b) · San Francisco, CA · 2026-07-08 | Allswell | Health & bio | Series A | $6.8M of $8.3MAmount sold of the amount offered on the filing of 2026-07-08 · as of 2026-10-04How this is computed → | 2026-07-08 | San Francisco, CA | 506(b) | 16The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively |